A global pharmaceutical distribution company is expanding its Dothan operations as part of a companywide $1 billion expansion throughout the U.S. Pennsylvania-based Cencora Wednesday announced it will ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to deliver on the “Pivot to Growth” strategy CEO Richard Francis had envisioned ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

A rebound in global biotech deals this year looks set to accelerate as big pharmaceutical companies seek new sources of revenue, according to a top-performing fund with a track record of identifying ...